| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2815631 | Gene | 2015 | 4 Pages |
•Genetic thrombophilia in 339/865 liver cirrhosis patients; 243 of them with PVT•PAI1 4G-4G or MTHFR 677TT increases 2–5 fold the risk of no virus cirrhosis and PVT.•Pivotal role of PAI-1 4G-4G and MTHFR 677TT in thrombo-fibrogenetic mechanisms•PAI-1 4G-4G and MTHFR 677TT screening in alcohol, cryptogenic cirrhosis patients•The need of new therapies for lowering the activity of hepatic stellate cells
The thrombophilic genetic factors (THRGFs), PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q and Prothrombin 20210A, were studied as risk factors in 865 Caucasian patients with liver cirrhosis, consecutively enrolled from June 2008 to January 2014. A total of 582 HCV, 80 HBV, 94 alcohol, (82 with more than one etiologic factor) and 191 cryptogenic patients with liver cirrhosis had been consecutively enrolled; 243 patients showed portal vein thrombosis (PVT). At least one of the above THRGFs was present in 339/865 patients (39.2%). PAI-1 4G-4G and MTHFR 677TT were the most frequent THRGFs, statistically significant in patients with alcohol, cryptogenic liver cirrhosis, and PVT: respectively 24 and 28, 50 and 73, and 65 and 83 (all chi-square tests > 3.84, and p values < 0.05). Two logistic regression analysis, using PAI-1 4G-4G and MTHFR 677TT, as dependent variable, confirmed the independent significant relationship of these THRGFs with alcohol, cryptogenic liver cirrhosis and PVT. PAI 1 and MTHFR 677 genotypes, deviated from those expected in populations in Hardy–Weinberg equilibrium (all p values < 0.05), in the subgroups of patients with alcohol, cryptogenic liver cirrhosis and presence of PVT. Our study shows the pivotal role of PAI-1 4G-4G and MTHFR 677TT in patients with alcohol, cryptogenic liver cirrhosis, and PVT, in a Caucasian population. In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677TT, could have a role in the development of liver cirrhosis, mainly in patients without HCV and HBV, and PVT.
